BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1645365)

  • 1. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.
    Schwarz TF; Modrow S; Hottenträger B; Höflacher B; Jäger G; Scharti W; Sumazakl R; Wolf H; Middeldorp J; Roggendorf M
    J Clin Microbiol; 1991 Mar; 29(3):431-5. PubMed ID: 1645365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro.
    Yaegashi N; Shiraishi H; Tada K; Yajima A; Sugamura K
    J Virol Methods; 1989 Nov; 26(2):171-81. PubMed ID: 2559100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic of parvovirus B19 infection.
    Schwarz TF; Roggendorf M
    Behring Inst Mitt; 1990 Aug; (85):35-8. PubMed ID: 2171483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.
    Anderson LJ; Tsou C; Parker RA; Chorba TL; Wulff H; Tattersall P; Mortimer PP
    J Clin Microbiol; 1986 Oct; 24(4):522-6. PubMed ID: 3021807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parvovirus B19: ELISA and immunoblot assays.
    Schwarz TF; Roggendorf M; Deinhardt F
    J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test.
    Morinet F; Courouce AM; Galibert F; Perol Y
    J Virol Methods; 1991 Apr; 32(1):21-30. PubMed ID: 1648571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG.
    Patou G; Ayliffe U
    J Clin Pathol; 1991 Oct; 44(10):831-4. PubMed ID: 1660053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI; Enders M; Motz M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.
    Kaikkonen L; Lankinen H; Harjunpää I; Hokynar K; Söderlund-Venermo M; Oker-Blom C; Hedman L; Hedman K
    J Clin Microbiol; 1999 Dec; 37(12):3952-6. PubMed ID: 10565913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
    Manaresi E; Gallinella G; Venturoli S; Zerbini M; Musiani M
    J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.
    Fridell E; Cohen BJ; Wahren B
    J Clin Microbiol; 1991 Jul; 29(7):1376-81. PubMed ID: 1653264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen.
    Brown CS; van Bussel MJ; Wassenaar AL; van Elsacker-Niele AM; Weiland HT; Salimans MM
    J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of parvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques.
    Us T; Ozune L; Kasifoglu N; Akgun Y
    Braz J Infect Dis; 2007 Jun; 11(3):327-30. PubMed ID: 17684634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S; O'Keeffe G; Kilty C; Doyle S
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant immunoblot and ELISA for detection of acute parvovirus B19 infection.
    Schwarz TF; Jäger G
    Zentralbl Bakteriol; 1994 Mar; 280(4):526-33. PubMed ID: 8061414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array-in-well serodiagnostic assay utilizing upconverting phosphor label technology.
    Ylihärsilä M; Alaranta S; Lahdenperä S; Lahtinen S; Arku B; Hedman K; Soukka T; Waris M
    J Virol Methods; 2015 Sep; 222():224-30. PubMed ID: 26028427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY; Lee KL; Hung CC
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.